Quoin Pharmaceuticals LTD DRC reports a Return on Equity (ROE) of -193.51%.

What is QNRX's dividend yield?

Quoin Pharmaceuticals LTD DRC offers a dividend yield of 0.00%.

What is QNRX's Quality Score?

Our AI rates QNRX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy QNRX?

Our AI Timing Score for QNRX is 1 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does QNRX belong to?

Quoin Pharmaceuticals LTD DRC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Quoin Pharmaceuticals LTD DRC (QNRX) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-06 | FS: 2026-03-31)

QNRX AI Analysis Summary

Our AI summary for QNRX: Quoin Pharmaceuticals LTD DRC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -193.51%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

QNRX

Quoin Pharmaceuticals LTD DRC

US:NASDAQ STOCK Healthcare >> Biotechnology News 86

USD 4.57

0.20 (4.58%) Day Change

Watchlist Portfolio Compare Chart

0.79

D/E

-193.5%

ROE

-108.2%

ROA

0.00%

Div Yield

QUOIN PHARMACEUTICALS LTD DRC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.57 Price 0.20 (4.58%) Day Change	NEWS SCORE: 86

QNRX, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	86
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.57
PBV / Sector	1.00 / 5.21 GREAT
Earning Per Share	-8.84

PE / Sector	N/A / 21.00
PEG or PE/Growth / Sector	N/A / 1.11
Average 1M Daily Value	0.06 M GREAT
Average 1W Daily Value	0.06 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 95.56
NPM Average (%) / Sector	N/A / -1,676.77
NPM Change Average (%) / Sector	N/A / 4,917.73
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-108.18 / 25.44
ROA Average (%) / Sector	-75.80 / -350.66
ROA Change Average (%) / Sector	16.34 / 5,110.09 GOOD
ROE (%) / Sector	-193.51 / 3.07
ROE Average (%) / Sector	-138.27 / 4.81
ROE Change Average (%) / Sector	17.23 / 2,068.02 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.02
Dividend Average (%) / Sector	N/A / 17.10
Dividend Change Average (%) / Sector	N/A / 0.98

Registration Details

Analyze Date	2026-08-07 08:12:12
Symbol	QNRX
Name	QUOIN PHARMACEUTICALS LTD DRC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	2.01 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	8.78 / 9,672.56

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349

Phone: 703 980 4182

Website: https://quoinpharma.com

Sector: Healthcare >> Biotechnology

Description: Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.